Golmehr Sistani

3PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMedical physicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 10, 2021
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS).

Mina M Swiha, Duncan E K Sutherland, Golmehr Sistani

|Mar 22, 2021
Spinal Intradural Phosphaturic Mesenchymal Tumor.

Golmehr Sistani, Yasmine Sallam, Wai P Ng

|Feb 24, 2021
Efficacy of 177Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study.

Golmehr Sistani, Duncan E K Sutherland, Amol Mujoomdar

Pageof 1

Frequent Collaborators

2 joint publications

Alireza Khatami

1 joint publications

Yasmine Sallam

1 joint publications

Andrew E Leung

1 joint publications

Mina M Swiha